What if my left hand wants to grab a cookie but my right one disagrees? A single-case study on chronic anarchic hand syndrome rehabilitation.

Neuropsychol RehabilJan 28, 2026 (epub)
Case ReportNeurology

Gaia Galluzzi, Fabiana Mogavero, Maddalena Boccia et al.

✦ AI-curated · Sources linked

Case in brief

A 26-year-old woman developed anarchic hand syndrome (AHS) after an intracerebral hemorrhage caused by rupture of an anterior communicating artery aneurysm. Neuropsychological assessment and brain lesion and tractography analyses were performed. Rehabilitation combined Mirror Box Treatment, targeting bottom-up mechanisms, with Verbal Order Treatment, targeting top-down mechanisms. Neuropsychological tests, structured interviews, and caregiver reports showed progressive improvement in motor and planning control, fewer AHS-related symptoms, and better quality of life; reported benefits persisted at follow-up. The single-case design did not permit direct comparison of the treatments’ efficacy.

What made this case unusual

The rehabilitation protocol paired mirror-box and verbal-order treatments to address both bottom-up and top-down mechanisms in chronic AHS, a syndrome for which the authors note that standardized rehabilitation treatments are lacking.

Diagnostic / clinical pearl

AHS can follow intracerebral hemorrhage from a ruptured anterior communicating artery aneurysm; assessment and caregiver reports can help track its effects on motor and planning control.

Why it matters

The case supports the feasibility of structured, multimodal rehabilitation for AHS, while not establishing the comparative efficacy of its components.

Source

Published in Neuropsychol Rehabil. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.